|
| Title |
|
|
|
Phase I/II study of refametinib (BAY 86-9766) in combination with gemcitabine in advanced pancreatic cancer
| |
| Author |
|
|
|
| |
| Abstract |
|
|
| | |
| Language |
|
|
|
English
| |
| Source (journal) |
|
|
|
Targeted oncology. - Paris | |
| Publication |
|
|
|
Paris : 2017
| |
| ISSN |
|
|
|
1776-2596
| |
| Volume/pages |
|
|
|
12:1(2017), p. 97-109
| |
| ISI |
|
|
|
000393121700010
| |
| Full text (Publisher's DOI) |
|
|
| | |
| Full text (publisher's version - intranet only) |
|
|
| | |
|
| Faculty/Department |
|
|
| | |
| Research group |
|
|
| | |
| Subject |
|
|
| | |
| Affiliation |
|
|
|
Publications with a UAntwerp address
| |
|
|
|
| Identification |
|
| |
|
|
| Creation |
|
| |
02.08.2018
|
|
| Last edited |
|
| |
05.09.2020
|
|
| To cite this reference |
|
|
| | |
|
| |